Skip to main content
OpenTrials
Completed

NCT Number: NCT04104763

Osteofibrous Dysplasia (Kempson-Campanacci's Disease)

The aim of the present study is to obtain long term follow-up in patients with osteofibrous dysplasia, to assess natural history of the disease, late results of treatment and in particular the potential and risk of progression to adamantinoma.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Osteofibrous Dysplasia

Sex eligibility

All sexes

Study type

Observational

Primary location

Dept. of Pathology of IRCCS Istituto Ortopedico Rizzoli

Bologna, 40136, Italy

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Male and female patients treated at Rizzoli Institute from 01 Jan 1943 to 31 Dic 2011
  • Diagnosis of osteofibrous dysplasia pathologically confirmed
  • Written informed consent prior to any study-specific analysis and/or data collection

Exclusion criteria

  • Patients with histological diagnosis different from osteofibrous dysplasia

Treatment and study plan

study of osteofibrous dysplasia features

Behavioral

obtain long term follow-up in patients with osteofibrous dysplasia, to assess natural history of the disease, late results of treatment and in particular the potential and risk of progression to adamantinoma.

Primary outcomes

  1. Osteofibrous Dysplasia (Kempson-Campanacci's disease): Long Term Follow-up Study on Natural History, Results of Treatment and Relationship with Adamantinoma

    Time frame: BASELINE

    We will retrieve from the database of the Rizzoli institute all the cases with a histological diagnosis of Ewing sarcoma from 01 Jan 1943 to 31 Dic 2011.

    We aspect to find approximately 55 cases. We will review all the medical records, radiological imaging, and histological data of these cases.

Sponsors and collaborators

Lead sponsor

Istituto Ortopedico Rizzoli

Other

Registry information

Official study title

Osteofibrous Dysplasia (Kempson-Campanacci's Disease): Long Term Follow-up Study on Natural History, Results of Treatment and Relationship With Adamantinoma

Acronym: DOFOL

Important dates

Study start
2019
Primary completion
2019
Study completion
2021
First posted
Sep 26, 2019
Registry last updated
Aug 23, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.